Nitration of the Pollen Allergen Bet v 1.0101 Enhances the Presentation of Bet v 1-Derived Peptides by HLA-DR on Human Dendritic Cells

• Anette C. Karle ,

  Contributed equally to this work with: Anette C. Karle, Gertie J. Oostingh

  Current address: Novartis Pharma AG, Basel, Switzerland

  Affiliation Immunosafety, Non-Clinical Drug Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
• Gertie J. Oostingh ,

  Contributed equally to this work with: Anette C. Karle, Gertie J. Oostingh

  Affiliation Department of Molecular Biology, University of Salzburg, Salzburg, Austria

  ⨯
• Sonja Mutschlechner,

  Affiliation Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria

  ⨯
• Fatima Ferreira,

  Affiliation Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Department of Molecular Biology, University of Salzburg, Salzburg, Austria

  ⨯
• Peter Lackner,

  Affiliation Department of Molecular Biology, University of Salzburg, Salzburg, Austria

  ⨯
• Barbara Bohle,

  Affiliation Christian Doppler Laboratory for Immunomodulation, Department of Pathophysiology, Center of Physiology, Pathophysiology and Immunology, Medical University of Vienna, Vienna, Austria

  ⨯
• Gottfried F. Fischer,

  Affiliation Clinical Department for Blood Group Serology, University Clinic for Blood Group Serology and Transfusion Medicine, Vienna, Austria

  ⨯
• Anne B. Vogt ,

  * E-mail: anne.vogt@roche.com

  Affiliation Immunosafety, Non-Clinical Drug Safety, F. Hoffmann-La Roche Ltd, Basel, Switzerland

  ⨯
• Albert Duschl

  Affiliation Department of Molecular Biology, University of Salzburg, Salzburg, Austria

  ⨯